Patent litigation is a complex and strategic endeavor, requiring thorough preparation and careful consideration. Before proceeding with a lawsuit, patent owners should evaluate several critical ...

In recent years, patent enforcement between operating companies has been overshadowed by non-practicing entity litigation. The Patent Trial and Appeal Board (PTAB) loomed large as a ...

"One key issue that has arisen in funded patent litigation is transparency—in other words, to what extent must funder involvement in a patent infringement action be revealed? This article tackles this ...

An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and Appeal Board’s (PTAB’s) approach to discretionary denials of inter partes review ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The landscape for discretionary denials at PTAB is evolving quickly; both patent challengers and owners must adapt their strategies to ensure they are not left behind by the USPTO’s new approach. The ...

Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.

Adeia Inc. (Nasdaq: ADEA), a technology licensing firm, has initiated a major legal battle against Advanced Micro Devices, Inc. (AMD), alleging that the chip giant has infringed on ten of its ...

"seven patents covering hybrid bonding technology and three patents covering advanced process node technology." How does a lawsuit like this even work when AMD does ...

Last year, we reported that patent practice in Japan has been shifting toward a pro‑patent stance. [1] Supporting this trend, a series of impactful court decisions have recently affirmed robust ...